You cannot register for this webinar

SESSION 1: EULAR Guideline Revisions (7-8PM) In this session, Dr. Laura Whitthall Garcia will delve into the European Alliance of Associations for Rheumatology & its crucial role in setting guidelines for lupus. She will discuss the current EULAR guidelines for lupus, recent changes to these guidelines, & the reasons behind these updates. Additionally, the session will explore how these guidelines are applied in diagnosing & treating lupus to ensure effective & standardized patient care. SESSION 2: Lupus Types Expanded (8-9PM) In this session, Dr. Murray Urowitz will provide a brief recap of Types 1 & 2 lupus, followed by an in-depth exploration of lupus types 3, 4, & beyond. He will discuss the implications of these classifications on ongoing lupus patient treatment & provide insights on how patients can effectively advocate for themselves as their disease evolves. The session aims to equip lupus patients with the knowledge & strategies to engage proactively with their care practitioners. SESSION 3: Biologics Explained (7-8PM) In this session,Dr. Amanda Steiman will demystify biologics by explaining what they are & how they function in treating diseases. She will highlight the differences between biologics & other treatment options, detailing how patients should prepare for biologic treatment, including necessary tests, vaccines, & potential side effects. Additionally, Dr. Steiman will compare infusion & subcutaneous methods, providing guidance on what patients can expect from each approach. SESSION 4: CAR T-Cell Therapy & Upcoming Treatments (8-9PM) In this session, Dr. Mark Matsos will provide an overview of emerging treatments for lupus, with a focus on CAR T-Cell Therapy. He will explain the fundamentals of CAR T-Cell Therapy & discuss how this innovative approach could revolutionize the treatment landscape for lupus patients. The session will offer a glimpse into the future of lupus care, highlighting the potential benefits & transformative impact